scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicDiabetes Drug

Topic: Diabetes Drug

Why do weight loss drugs work for some and not for others? New study finds

A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for their effectiveness in reducing body weight.

India sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arena

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.

In Brazil’s São Paulo, armed gangs on the hunt for something more sought-after than gold—Ozempic

Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been reported in Michigan, US, and Santiago de Copostela, Spain. 

I was a pregnant penguin, see my before-after pics. 66-yr-old’s Ozempic to Mounjaro journey

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and the obese, but everyone wants in—even those who don’t need them.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.